Kabra Drugs share news, announcements and annual reports
BSE: 524322Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 29 Oct 2026. Previous close ₹16.26.
29 Oct: open ₹15.76, high ₹16.60, low ₹15.50
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹37 Cr3,225th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 4.91
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 28.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 52,888
Kabra Drugs has 557 announcements on record, routine notices left out; 1 in the 30 days to 30 Oct 2026, the latest on 1 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Kabra Drugs quarterly results
The board met on 12 Aug 2026 to consider quarterly results
Notice filed 5 Aug 2026
Kabra Drugs annual reports, presentations and earnings calls
The company's own documents, latest first.Kabra Drugs financials, year by year
Annual reports20
- Annual report, year to Mar 20268 Sep 2026
- Annual report, year to Mar 20259 Sep 2025
- Annual report, year to Mar 20249 Sep 2024
- Annual report, year to Mar 202325 Oct 2023
- Annual report, year to Mar 202229 Sep 2022
15 earlier reports
- Annual report, year to Mar 20218 Sep 2021
- Annual report, year to Mar 20209 Sep 2020
- Annual report, year to Mar 201928 Sep 2019
- Annual report, year to Mar 201821 Aug 2018
- Annual report, year to Mar 20174 Oct 2017
- Annual report, year to Mar 20168 Oct 2016
- Annual report, year to Mar 20157 Sep 2015
- Annual report, year to Mar 20142 Apr 2015
- Annual report, year to Mar 201120 Dec 2012
- Annual report, year to Mar 201019 Jul 2011
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1997Filing day not known
Kabra Drugs share news and announcements
Newest first. Page 1 of 12.
Oct 2026
1 Oct · Meeting
Sep 2026
30 Sep · Meeting
7 Sep · Meeting
3 Sep · Meeting
2 Sep · Management
2 Sep · Management
2 Sep · Board meeting
Aug 2026
29 Aug · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
27 Aug · Board meeting
Meeting on 2 Sep 202612 Aug · Management
12 Aug · Undertaking For Non- Applicability Of Regulation 32 Of SEBI
12 Aug · Results
12 Aug · Results
5 Aug · Board meeting
Meeting on 12 Aug 2026: quarterly results
Jul 2026
7 Jul · Announcement under Regulation 30 (LODR)-Change of Company Name
Jun 2026
13 Jun · Revised Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of Rs. 200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma Park
13 Jun · Receipt Of Letter Of Intent From Chhattisgarh Government For Proposed Investment Of ?200 Crore In Pharmaceutical Manufacturing Project At Nava Raipur Pharma Park
12 Jun · Meeting
12 Jun · Meeting
May 2026
29 May · Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On 31St March 2026.
29 May · Results
29 May · Results
21 May · Board meeting
Meeting on 29 May 2026: quarterly results8 May · Meeting
6 May · Business
Apr 2026
27 Apr · Board meeting
Meeting on 6 May 202610 Apr · Board meeting
Meeting on 21 Apr 2026
Mar 2026
Feb 2026
26 Feb · Board meeting
Meeting on 7 Mar 202613 Feb · Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On 31St December 2025.
13 Feb · Results
13 Feb · Results
6 Feb · Board meeting
Meeting on 13 Feb 2026: quarterly results
Jan 2026
1 Jan · Board meeting
Dec 2025
27 Dec · Meeting
26 Dec · Meeting
22 Dec · Board meeting
Meeting on 1 Jan 2026
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 13 Aug 2026Board or managers changeddown 3.36%−3.3 pts vs Nifty 500market median 0.0% · five sessions −11.2% (−10.0 pts vs Nifty 500) · volume 1.9× usual · The announcement
- 1 Dec 2025Board or managers changedup 0.64%+0.7 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−7.9 pts vs Nifty 500) · volume 1.5× usual · The announcement
- 9 Oct 2025Board or managers changedup 4.96%+4.4 pts vs Nifty 500market median 0.0% · five sessions +4.6% (+3.4 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 18 Jul 2022Board or managers changeddown 4.77%−5.5 pts vs Nifty 500market median 0.0% · five sessions +9.5% (+0.5 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 31 May 2022Board or managers changeddown 3.85%−3.6 pts vs Nifty 500market median 0.0% · five sessions +16.3% (+17.9 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 19 Apr 2022Board or managers changed0.00%+1.3 pts vs Nifty 500market median 0.0% · five sessions −17.9% (−16.9 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 17 Mar 2022Board or managers changed–market median 0.0% · volume 0.9× usual · The announcement
- 24 Aug 2018Board or managers changeddown 4.80%−4.6 pts vs Nifty 500market median 0.0% · five sessions −17.5% (−18.5 pts vs Nifty 500) · volume 2.1× usual · The announcement
- 10 Jul 2018Board or managers changed–market median 0.0% · volume 0.2× usual · The announcement
- 5 Dec 2017Board or managers changed–market median 0.0% · five sessions −21.6% (−23.4 pts vs Nifty 500) · volume 0.0× usual · The announcement
3 earlier announcements
- 30 Oct 2017Board or managers changedup 4.82%+4.2 pts vs Nifty 500market median 0.0% · five sessions +22.0% (+21.4 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 27 Oct 2017Board or managers changedup 4.73%+3.5 pts vs Nifty 500market median 0.0% · five sessions +26.8% (+23.7 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 20 Sep 2017Board or managers changeddown 4.86%−5.4 pts vs Nifty 500market median 0.0% · five sessions −13.7% (−11.1 pts vs Nifty 500) · volume 1.6× usual · The announcement